Studying the Brain-Gut Axis with Pharmacological Imaging

Center for Neurobiology of Stress, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-6949, USA.
Annals of the New York Academy of Sciences (Impact Factor: 4.38). 12/2008; 1144(1):256-64. DOI: 10.1196/annals.1418.025
Source: PubMed


Pharmacological imaging provides great potential both for evaluating the efficacy of new candidate compounds in the treatment of gastrointestinal symptom-based disorders, and for furthering our understanding of the underlying pathophysiology of such disorders. By combining evaluation of symptoms, behavior, and brain responses to relevant stimuli, use of neuroimaging is able to move the study of brain-gut disorders away from more subjective outcomes and emphasize the underlying neural networks involved in symptom generation and treatment. This chapter reviews the state of the art in pharmacological imaging studies, both in human subjects and in animal models of brain-gut interactions.

Download full-text


Available from: Emeran A Mayer, Mar 11, 2014
  • Source
    • "These findings provide further support for the face and construct validity of the WAS animal model for human IBS. Functional brain mapping in awake, nonrestrained rodents can be a powerful tool for bridging animal and human visceral pain research, for gaining new mechanistic insights, and for preclinical drug evaluation with presumably greater predictive power [80]. Future work will need to evaluate if activation/deactivation patterns reported in our study would be different and allow for animal-to-human translation if another painful stressor were used (e.g. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Repeated water avoidance stress (WAS) induces sustained visceral hyperalgesia (VH) in rats measured as enhanced visceromotor response to colorectal distension (CRD). This model incorporates two characteristic features of human irritable bowel syndrome (IBS), VH and a prominent role of stress in the onset and exacerbation of IBS symptoms. Little is known regarding central mechanisms underlying the stress-induced VH. Here, we applied an autoradiographic perfusion method to map regional and network-level neural correlates of VH. Adult male rats were exposed to WAS or sham treatment for 1 hour/day for 10 days. The visceromotor response was measured before and after the treatment. Cerebral blood flow (CBF) mapping was performed by intravenous injection of radiotracer ([(14)C]-iodoantipyrine) while the rat was receiving a 60-mmHg CRD or no distension. Regional CBF-related tissue radioactivity was quantified in autoradiographic images of brain slices and analyzed in 3-dimensionally reconstructed brains with statistical parametric mapping. Compared to sham rats, stressed rats showed VH in association with greater CRD-evoked activation in the insular cortex, amygdala, and hypothalamus, but reduced activation in the prelimbic area (PrL) of prefrontal cortex. We constrained results of seed correlation analysis by known structural connectivity of the PrL to generate structurally linked functional connectivity (SLFC) of the PrL. Dramatic differences in the SLFC of PrL were noted between stressed and sham rats under distension. In particular, sham rats showed negative correlation between the PrL and amygdala, which was absent in stressed rats. The altered pattern of functional brain activation is in general agreement with that observed in IBS patients in human brain imaging studies, providing further support for the face and construct validity of the WAS model for IBS. The absence of prefrontal cortex-amygdala anticorrelation in stressed rats is consistent with the notion that impaired corticolimbic modulation acts as a central mechanism underlying stress-induced VH.
    PLoS ONE 03/2013; 8(3):e59138. DOI:10.1371/journal.pone.0059138 · 3.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The majority of functional gastrointestinal disorders are characterised by recurrent abdominal pain, with stress playing an important role in first onset and exacerbation of existing symptoms. These disorders are currently defined by symptom criteria, while their pathophysiology remains controversial and incompletely understood. Modeling these disorders in humans and animals has been difficult. While some of the models have adequate face and construct validity, the predictive validity of most of the models has been disappointing, which has put into question the traditional modeling approach. Similar problems have been encountered in drug development for pain and psychiatric disorders. New approaches have been proposed in the form of reverse translation, which include better characterisation of biological intermediate phenotypes in human disease which can be modeled in humans and in animals. Continuation of the current approach focusing on complex clinical phenotypes is likely to be ineffective for the development of novel and effect treatments.
    Digestive Diseases 01/2009; 27 Suppl 1(1):55-67. DOI:10.1159/000268122 · 2.18 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Evaluation of: Silk DBA, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide on faecal microbiota and symptoms in irritable bowel syndrome. Aliment. Pharmacol. Ther. 29, 508-518 (2009). While a variety of probiotic preparations have been quite extensively studied in the short-term treatment of irritable bowel syndrome (IBS), little is known regarding the efficacy of prebiotics - the nondigestible but fermentable foods that promote the growth of one or a number of species of beneficial commensal flora in the human colon - in IBS. In this study, a specially designed prebiotic, a trans-galactooligosaccharide, was studied in two doses, 3.5 and 7 g, in a single-blind, randomized, placebo-controlled trial of 4-weeks duration in Rome II-positive IBS patients. The researchers found that the prebiotic altered the fecal flora, increasing the numbers of Bifidobacteria in a dose-dependent manner and also improved, but in a less predictable manner, individual IBS symptoms, such as flatulence and bloating, as well as impacting on a composite score of the subjects' global assessment of relief and quality of life. This study indicates that prebiotics, either on their own or in combination with a probiotic, deserve further study in IBS.
    Expert review of gastroenterology & hepatology 10/2009; 3(5):487-92. DOI:10.1586/egh.09.46 · 2.42 Impact Factor
Show more